After hours: January 22 at 6:58:43 PM EST ...
The cancer/testis antigen New York esophageal squamous cell carcinoma 1 (NY-ESO-1) is a promising target in myxoid/round cell liposarcoma (MRCLS). In this pilot study, we assessed the adoptive T-cell ...